<div id="readability-page-1">11:27 AM EST, 12/18/2025 (MT Newswires) -- Lixte Biotechnology ( LIXT ) said Thursday that it launched an approximately $4.3 million registered direct offering of common stock along with pre-funded and investor warrants at $4.09 per unit.The offering consisted of about 1.1 million units, each including one share of common stock or a pre-funded warrant, plus one common warrant to buy one common share per warrant, the company said.Net proceeds will be used for general corporate purposes and working capital, the company said.The offering is expected to close by Friday.Lixte Biotechnology ( LIXT ) shares were down over 2% in recent trading.Price: 3.87, Change: -0.09, Percent Change: -2.40 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

LIXT

Lixte Biotechnology 宣布进行一项价值 430 万美元的注册直接发行普通股，包括以每单位 4.09 美元的价格预先融资和投资者认股权证。此次发行包括约 110 万个单位，每个单位包含一股普通股或一个预先融资认股权证，以及一个普通认股权证。所得款项将用于一般企业用途和营运资金。此次发行预计将在周五之前完成。Lixte Biotechnology 的股票在最近的交易中下跌超过 2%

Lixte Biotechnology 启动了价值 430 万美元的注册直接发行